Marcel Borger

Marcel Borger

26 Jun, 2025

“We had a very good experience working alongside the Celegence medical device services team when drafting our clinical evaluation processes, and truly appreciate their highly professional and cooperative global regulatory experts. They took great care in understanding our CER/CEP and PSUR submission requirements.”

Other Related Articles

AI Compliance in Pharma: EU, US & UK Legislative Insights

Blog Pharmaceutical

AI Compliance in Pharma: EU, US & UK Legislative Insights

30 Jul, 2025

Celegence Pioneers Industry-First Automation of CMC Module 3 Document Creation with Generative AI

Company News

Celegence Pioneers Industry-First Automation of CMC Module 3 Document Creation with Generative AI

28 Jul, 2025

The Transformative Power of AI-Driven CMC Writing in Modern Pharmaceutical Development

Blog Pharmaceutical

The Transformative Power of AI-Driven CMC Writing in Modern Pharmaceutical Development

25 Jul, 2025

Common Challenges in DMF Submissions and How to Avoid Them

Blog Pharmaceutical

Common Challenges in DMF Submissions and How to Avoid Them

14 Jul, 2025

Understanding Drug Master Files (DMFs): Purpose, Types & Global Importance

Blog Pharmaceutical

Understanding Drug Master Files (DMFs): Purpose, Types & Global Importance

27 Jun, 2025

The UK Clinical Trials Regulation Overhaul

Blog Pharmaceutical

The UK Clinical Trials Regulation Overhaul

23 Jun, 2025

The Windsor Framework: Minimally Impacted Procedures

Blog Pharmaceutical

The Windsor Framework: Minimally Impacted Procedures

16 Jun, 2025

The Windsor Framework: Procedural Impact

Blog Pharmaceutical

The Windsor Framework: Procedural Impact

13 Jun, 2025

View All